Drug Type Monoclonal antibody |
Synonyms FFP 104, FFP104, FFP104-001 |
Target |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Phase 2 | BE | 01 Jan 2016 | |
Crohn Disease | Phase 2 | NL | 01 Jan 2016 | |
Primary Biliary Cholangitis | Phase 2 | NL | 01 May 2015 | |
Primary Biliary Cholangitis | Phase 2 | GB | 01 May 2015 | |
Liver Cirrhosis, Biliary | Phase 2 | NL | 01 May 2015 | |
Liver Cirrhosis, Biliary | Phase 2 | GB | 01 May 2015 |